{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:00:43Z","timestamp":1785902443264,"version":"3.56.0"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Heart Journal"],"published-print":{"date-parts":[[2002,9,15]]},"DOI":"10.1053\/euhj.2001.3158","type":"journal-article","created":{"date-parts":[[2002,10,9]],"date-time":"2002-10-09T16:53:46Z","timestamp":1034182426000},"page":"1422-1432","source":"Crossref","is-referenced-by-count":452,"title":["Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN)"],"prefix":"10.1093","volume":"23","author":[{"given":"V","family":"Moiseyev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/23\/18\/1422\/17885235\/1422.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T19:34:19Z","timestamp":1503430459000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1053\/euhj.2001.3158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9,15]]},"references-count":0,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2002,9,15]]}},"alternative-id":["S0195-668X(01)93158-6"],"URL":"https:\/\/doi.org\/10.1053\/euhj.2001.3158","relation":{},"ISSN":["0195-668X"],"issn-type":[{"value":"0195-668X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,9,15]]}}}